Notice · For research and educational reference. Not medical advice. Intended for licensed professionals. Nothing on this site is offered for sale other than informational access.

All Info Peptides
All categories

Category

Longevity & Mitochondrial

Mitochondrial-derived peptides and senescence-modulating compounds investigated in aging biology.

Longevity & Mitochondrial

5-Amino-1MQ

5-amino-1-methylquinolinium

5-AMINO-1MQ
MW
159.2 g/mol
Half-life
Not formally characterised in humans
Class
Small-molecule NNMT inhibitor (non-peptide)

Longevity & Mitochondrial

Epitalon

Epithalon · Epithalamin tetrapeptide

EPITALON
MW
390.35 g/mol
Half-life
Short (minutes)
Class
Synthetic tetrapeptide

Longevity & Mitochondrial

FOXO4-DRI

FOXO4 D-retro-inverso peptide

FOXO4-DRI
MW
≈ 5100 g/mol
Half-life
Extended by D-amino-acid protease resistance
Class
Senolytic peptide (p53-FOXO4 interaction disruptor)

Longevity & Mitochondrial

Humanin

HN · HNG (potent analogue)

HUMANIN
MW
2687.2 g/mol
Half-life
Short in plasma; analogues extended
Class
Mitochondrial-derived peptide

Longevity & Mitochondrial

MOTS-c

MOTS-C
MW
2174.6 g/mol
Half-life
Short (preclinical)
Class
Mitochondrial-derived peptide (MDP)

Longevity & Mitochondrial

NAD+

Nicotinamide Adenine Dinucleotide

NAD-PLUS
MW
663.4 g/mol
Half-life
Tissue-specific; intracellular pool turns over within hours
Class
Pyridine dinucleotide coenzyme (not a peptide)

Longevity & Mitochondrial

SS-31

Elamipretide · MTP-131 · Bendavia

SS-31
MW
639.8 g/mol
Half-life
≈ 2–4 h (SC)
Class
Mitochondria-targeted tetrapeptide